Fig. 1From: Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world dataDecrease of NT-proBNP levels and improvement of LV-ejection fraction after treatment with sacubitril/valsartan (n = 21). Abbreviations: NT-proBNP N-terminal pro B-type natriuretic peptide, LV-EF left ventricular ejection fractionBack to article page